1. Home
  2. GMM vs ENSC Comparison

GMM vs ENSC Comparison

Compare GMM & ENSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GMM
  • ENSC
  • Stock Information
  • Founded
  • GMM 2017
  • ENSC 2003
  • Country
  • GMM China
  • ENSC United States
  • Employees
  • GMM N/A
  • ENSC N/A
  • Industry
  • GMM
  • ENSC Biotechnology: Pharmaceutical Preparations
  • Sector
  • GMM
  • ENSC Health Care
  • Exchange
  • GMM Nasdaq
  • ENSC Nasdaq
  • Market Cap
  • GMM 9.8M
  • ENSC 7.9M
  • IPO Year
  • GMM 2023
  • ENSC N/A
  • Fundamental
  • Price
  • GMM $3.34
  • ENSC $8.10
  • Analyst Decision
  • GMM
  • ENSC
  • Analyst Count
  • GMM 0
  • ENSC 0
  • Target Price
  • GMM N/A
  • ENSC N/A
  • AVG Volume (30 Days)
  • GMM 130.6K
  • ENSC 186.5K
  • Earning Date
  • GMM 01-29-2025
  • ENSC 11-12-2024
  • Dividend Yield
  • GMM N/A
  • ENSC N/A
  • EPS Growth
  • GMM N/A
  • ENSC N/A
  • EPS
  • GMM 9.03
  • ENSC N/A
  • Revenue
  • GMM $33,985,284.00
  • ENSC $4,421,404.00
  • Revenue This Year
  • GMM N/A
  • ENSC $12.04
  • Revenue Next Year
  • GMM N/A
  • ENSC N/A
  • P/E Ratio
  • GMM $0.37
  • ENSC N/A
  • Revenue Growth
  • GMM 59.78
  • ENSC 40.41
  • 52 Week Low
  • GMM $0.21
  • ENSC $2.12
  • 52 Week High
  • GMM $11.50
  • ENSC $30.90
  • Technical
  • Relative Strength Index (RSI)
  • GMM 57.79
  • ENSC 54.16
  • Support Level
  • GMM $3.10
  • ENSC $5.96
  • Resistance Level
  • GMM $4.15
  • ENSC $8.81
  • Average True Range (ATR)
  • GMM 0.53
  • ENSC 1.15
  • MACD
  • GMM -0.11
  • ENSC 0.02
  • Stochastic Oscillator
  • GMM 19.88
  • ENSC 79.31

About GMM Global Mofy Metaverse Limited

Global Mofy AI Ltd, formerly Global Mofy Metaverse Ltd operates as a technology solutions provider engaged in virtual content production, digital marketing, and digital assets development for the metaverse industry. It utilizes its proprietary Mofy Lab technology platform which consists of three-dimensional (3D) rebuilt technology and artificial intelligence (AI) interactive technology to create a 3D high-definition virtual version of a wide range of physical world objects such as human, animal, and scenes which can be used in different applications.

About ENSC Ensysce Biosciences Inc.

Ensysce Biosciences Inc is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs. The company is developing a new class of powerful, tamper-proof opioids that prevent both drug abuse and overdoses. Its products are anticipated to provide safer options to treat severe pain and assist in preventing deaths caused by opioid abuse, reducing human and economic costs. The company's current development pipeline includes two new drug platforms: an abuse-resistant opioid prodrug technology, the Trypsin Activated Abuse Protection, or the TAAP platform, and an over-dose protection opioid prodrug technology, the Multi-Pill Abuse Resistant, or the MPAR platform. The Company currently operates in one business segment, which is pharmaceuticals.

Share on Social Networks: